Anticorps Monoclonal anti-CYLD

CYLD Monoclonal Antibody for IF, WB, ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, Lapin, porc, rat, souris

Applications

WB, IF, ELISA

Conjugaison

Non conjugué

CloneNo.

1G2F4

N° de cat : 66858-1-Ig

Synonymes

CDMT, CYLD, CYLD1, CYLDI, Deubiquitinating enzyme CYLD, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, Ubiquitin thiolesterase CYLD, USPL2

---

Galerie de données de validation

• 

  WB analysis using 66858-1-Ig

  Various lysates were subjected to SDS PAGE followed by western blot with 66858-1-Ig (CYLD antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours. The membrane was stripped and reblotted with HRP-conjugated Alpha Tubulin Monoclonal antibody (HRP-66031) as loading control.

• 

  WB analysis using 66858-1-Ig

  Various lysates were subjected to SDS PAGE followed by western blot with 66858-1-Ig (CYLD antibody) at dilution of 1:1500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HEK-293 using 66858-1-Ig

  HEK-293 cells were subjected to SDS PAGE followed by western blot with 66858-1-Ig (CYLD antibody) at dilution of 1:1500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of A431 using 66858-1-Ig

  A431 cells were subjected to SDS PAGE followed by western blot with 66858-1-Ig (CYLD antibody) at dilution of 1:1500 incubated at room temperature for 1.5 hours.

• 

  IF Staining of SH-SY5Y using 66858-1-Ig

  Immunofluorescent analysis of (4% PFA) fixed SH-SY5Y cells using CYLD antibody (66858-1-Ig, Clone: 1G2F4 ) at dilution of 1:100 and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L).

• 

  IF Staining of SH-SY5Y using 66858-1-Ig

  Immunofluorescent analysis of (4% PFA) fixed SH-SY5Y cells using CYLD antibody (66858-1-Ig, Clone: 1G2F4 ) at dilution of 1:100 and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L).

---

Applications testées

• Résultats positifs en WB: tissu cérébral de porc, cellules A431, cellules HEK-293, tissu cérébral de lapin, tissu cérébral de rat, tissu cérébral de souris
• Résultats positifs en IF: cellules SH-SY5Y,

Dilution recommandée

• Western Blot (WB): WB : 1:1000-1:6000
• Immunofluorescence (IF): IF : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Informations sur le produit

66858-1-Ig cible CYLD dans les applications de WB, IF, ELISA et montre une réactivité avec des échantillons Humain, Lapin, porc, rat, souris

• Réactivité: Humain, Lapin, porc, rat, souris
• Hôte / Isotype: Mouse / IgG2a
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: CYLD Protéine recombinante Ag28333
• Nom complet: cylindromatosis (turban tumor syndrome)
• Masse moléculaire calculée: 107 kDa
• Poids moléculaire observé: 110 kDa
• Numéro d’acquisition GenBank: BC012342
• Symbole du gène: CYLD
• Identification du gène (NCBI): 1540
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

CYLD, also named as CYLD1, belongs to the peptidase C67 family. It is the protease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. CYLD has endodeubiquitinase activity and plays an important role in the regulation of pathways leading to NF-kappa-B activation. CYLD contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation. It is a negative regulator of Wnt signaling. CYLD inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules. CYLD plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis. It is required for normal cell cycle progress and normal cytokinesis. CYLD inhibits nuclear translocation of NF-kappa-B and plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation. It is dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells. CYLD negatively regulates TNFRSF11A signaling and osteoclastogenesis.